A detailed history of Hrt Financial LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 67,004 shares of GH stock, worth $1.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,004
Holding current value
$1.95 Million
% of portfolio
0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$22.3 - $36.29 $1.49 Million - $2.43 Million
67,004 New
67,004 $1.54 Million
Q1 2024

May 13, 2024

BUY
$17.13 - $26.91 $194,613 - $305,724
11,361 New
11,361 $234,000
Q3 2023

Nov 13, 2023

BUY
$25.8 - $39.97 $1.29 Million - $2 Million
49,977 New
49,977 $1.48 Million
Q1 2023

May 12, 2023

BUY
$22.92 - $33.76 $1.32 Million - $1.95 Million
57,657 New
57,657 $1.35 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $1.13 Million - $1.59 Million
25,996 New
25,996 $1.4 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $1.26 Million - $2.62 Million
-26,033 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $2.31 Million - $3.14 Million
26,033 New
26,033 $2.6 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $2.53 Million - $3.39 Million
-25,638 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $5.52 Million - $8.33 Million
-50,271 Reduced 66.23%
25,638 $3.18 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $895,123 - $1.26 Million
-7,046 Reduced 8.49%
75,909 $11.6 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $8.29 Million - $11.3 Million
82,955 New
82,955 $10.7 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.98B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.